Dr David Inwald
MB BChir PhD FRCPCH FFICM
Bye-Fellow; Director of Studies in Medicine
Consultant in Paediatric Intensive Care, Addenbrooke's Hospital
David qualified from Cambridge University (he was an undergraduate at Emmanuel) and trained in adult and paediatric medicine before completing his training in paediatric intensive care medicine at Great Ormond Street Hospital for Children, London. During this time he also completed his PhD in platelet physiology at the Institute of Child Health at University College London. He also has an MA in Medical Law and Ethics from King's College London. He is a Consultant in Paediatric Intensive Care at Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust and a Bye-Fellow in Medicine at Emmanuel College.
Medical Sciences and Clinical Medicine. Ethics and Law in Medicine.
Clinical trials, pathophysiology and management of sepsis and patient safety in critically ill children. Chief Investigator on the recent FiSh (Fluids in Shock) trial and Chair of the Haemodynamics Group in the SCCM/ESICM Pediatric Sepsis Guideline update (currently in progress). Chief Investigator of PRESSURE (PRotocolised Evaluation of permiSSive blood pressure targets versus Usual caRE) - a planned randomised controlled trial to evaluate the clinical and cost effectiveness of using a more permissive blood pressure target to guide titration of vasoactive agents in critically ill children with hypotension. Led the recent Paediatric Intensive Care Society survey of staff mental health and wellbeing in UK Paediatric Intensive Care staff. See Researchgate webpage (under "Links" below) for a full listing of research and publications.